Effects of OsteoStrong vs. Individually Adapted and Combined Training on Bone Health

April 9, 2024 updated by: Helena Salminen, Karolinska Institutet

Effects of OsteoStrong vs. Individually Adapted and Combined Training on Bone Health Amongst Older Women With High Fracture Risk: A Randomised Controlled Trial

The aim of this clinical trial is to investigate the effect of the OsteoStrong training method and the Individually Adapted and Combined Training on the bone health of older women with high fracture risk. Additionally, the aim is also to explore the participants' experiences of each training method.

Participants will be randomised to either treatment arm A (OsteoStrong) or treatment arm B (Individually Adapted and Combined Training). Participants in both groups will train for nine months. Treatment arm A will train individually once a week and treatment arm B will train in a group twice a week. Both groups will have a training instructor who will supervise and give training instructions.

Researchers will compare the groups to see the effects of the training methods on the participants' bone health among other outcome measures. The participants will be tested at baseline and post-intervention (9 months later).

Study Overview

Study Type

Interventional

Enrollment (Actual)

194

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Stockholms Län
      • Huddinge, Stockholms Län, Sweden, 141 52
        • Karolinska Institutet - Department of Neurobiology, Care Sciences and Society: Division of Family medicine and Primary care

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 79 years (Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Woman, 65-79 years old.
  • Vaccinated against Covid-19.
  • Be able to participate in nine months of training.
  • Untreated with Osteoporosis-medications, or have an ongoing treatment since at least one year back.

Exclusion Criteria:

  • Ongoing treatment with Osteoporosis-medications with an onset within a year, or a previous treatment which was terminated within the last five years.
  • Ongoing treatment with Osteoporosis-medications that has been delayed for more than eight months for Denosumab, or more than 18 months for bisphosphonates.
  • Vertebral fracture, that have been diagnosed within three months.
  • Vertebral fracture or hip fracture, that have not previously been treated with Osteoporosis-medications or been assessed by a physician.
  • Bilateral hip replacements.
  • Symptomatic disc herniation, inguinal herniation or umbilical herniation.
  • Untreated hypertension.
  • Other diseases that can affect the results and participation in the study: malignant diseases, muscle dystrophy, secondary osteoporosis, or other conditions that would hinder study participation.
  • Ongoing treatment with oral cortisone pills (≥ 5 mg Prednisolone).
  • Conditions that hinders the conduction of impact microindentation with OsteoProbe: large edema, skin infection, allergy towards local anaesthetics.
  • Ongoing or previous training (within the last year) at OsteoStrong.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: OsteoStrong
Training following the OsteoStrong-method.

This training method is an isometric high-impact loading in four different training machines (Spectrum) and balance training on a vibration plate. The four machines are "chest press", "leg press", "pull-down" and "deadlift". The participants press and/or pull isometrically for around 10-15 seconds 1-3 times on every machine.

The training session takes around 20 minutes and is performed individually by the participants with the help of a training instructor.

Active Comparator: Individually Adapted and Combined Physical Training
Training based on current recommendations on exercise for people with osteoporosis.

This training method is based on the current recommendations on physical activity for people with osteoporosis.

The training is divided into two training sessions:

Circuit training with ten stations with different exercises for the whole body (strength, balance, endurance, weight-bearing). The participants spend 40 seconds on each station. This is repeated during 40 minutes. The training session starts with a joint warm-up and ends with a cool-down.

Strength training with machines for the whole body with the intensity of up to 70-80 % of one repetition max (1RM). The training session starts with a joint warm-up and and a voluntary individual cool-down.

The training session takes around 60 minutes and is performed in a group with the help of a training instructor. The participants also have the option to do a home based exercise programme that they could do in a few cases when they were unable to attend the physical group training.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bone Material Strength Index (BMSI)
Time Frame: Change from baseline at 9 months
Bone Material Strength Index measured with impact microindentation using OsteoProbe
Change from baseline at 9 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bone Mineral Density (BMD)
Time Frame: Change from baseline at 9 months
Bone Mineral Density and T-score measured with Dual-Energy X-ray Absorptiometry (DXA)
Change from baseline at 9 months
Procollagen Type 1 N-terminal propeptide (S-PINP)
Time Frame: Change from baseline at 3 and 9 months
Bone biomarker
Change from baseline at 3 and 9 months
Serum C-telopeptide cross-link type 1 collagen (S-CTX)
Time Frame: Change from baseline at 3 and 9 months
Bone biomarker
Change from baseline at 3 and 9 months
Sclerostin
Time Frame: Change from baseline at 3 and 9 months
Bone biomarker
Change from baseline at 3 and 9 months
Bone alkaline phosphatase (S-BALP)
Time Frame: Change from baseline at 3 and 9 months
Bone biomarker
Change from baseline at 3 and 9 months
Self-rated health questionnaire (SF-36)
Time Frame: Change from baseline at 9 months
A questionnaire with multiple choice questions about general health
Change from baseline at 9 months
Falls Efficacy Scale (FES)
Time Frame: Change from baseline at 9 months
A questionnaire about self-efficacy and fear of falling, 1-10, where 0 equals "not sure at all" and 10 equals "completely sure". Higher scores equals better outcome.
Change from baseline at 9 months
Socialstyrelsens questionnaire for lifestyle habits
Time Frame: Change from baseline at 9 months
A questionnaire with multiple choice questions about falls and fractures, physical activity, sitting, alcohol and smoking
Change from baseline at 9 months
Numerical Rating Scale (NRS)
Time Frame: Change from baseline at 3 and 9 months
A pain rating scale from 0-10, where 0 equals "no pain" and 10 equals "maximum/worst possible pain imaginable". Higher scores equals worse outcome.
Change from baseline at 3 and 9 months
Back extension strength
Time Frame: Change from baseline at 9 months
Measuring back extension strength with Digimax
Change from baseline at 9 months
Grip strength
Time Frame: Change from baseline at 9 months
Measuring grip strength with hand dynamometer (JAMAR)
Change from baseline at 9 months
Chair stand test
Time Frame: Change from baseline at 9 months
5 seconds, 30 seconds and time for making 50 chair stands
Change from baseline at 9 months
Back extension endurance
Time Frame: Change from baseline at 9 months
Measuring back extension endurance with Sörensen's test
Change from baseline at 9 months
Static sit-up
Time Frame: Change from baseline at 9 months
Sitting with the upper body in 45 degrees
Change from baseline at 9 months
Lung capacity
Time Frame: Change from baseline at 9 months
Lung capacity measured with dynamic spirometry (Welch Allyn)
Change from baseline at 9 months
One leg standing (eyes open)
Time Frame: Change from baseline at 9 months
Balance test
Change from baseline at 9 months
One leg standing (eyes closed)
Time Frame: Change from baseline at 9 months
Balance test
Change from baseline at 9 months
Two leg standing on a straight line (eyes open)
Time Frame: Change from baseline at 9 months
Balance test
Change from baseline at 9 months
Two leg standing on a straight line (eyes closed)
Time Frame: Change from baseline at 9 months
Balance test
Change from baseline at 9 months
Walking forward on a straight line
Time Frame: Change from baseline at 9 months
Balance test
Change from baseline at 9 months
Walking backwards between to lines
Time Frame: Change from baseline at 9 months
Balance test
Change from baseline at 9 months
BtrackS
Time Frame: Change from baseline at 9 months
Balance test, measuring body sway, standing on a platform with both legs together, arms crossed and eyes closed.
Change from baseline at 9 months
Accelerometry
Time Frame: Change from baseline at 9 months
Accelerometers worn around the waist to measure physical activity levels for up to nine days.
Change from baseline at 9 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Helena Salminen, Ass. prof., Karolinska Institutet

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 4, 2021

Primary Completion (Actual)

July 12, 2023

Study Completion (Actual)

February 14, 2024

Study Registration Dates

First Submitted

January 20, 2023

First Submitted That Met QC Criteria

January 31, 2023

First Posted (Actual)

February 9, 2023

Study Record Updates

Last Update Posted (Actual)

April 10, 2024

Last Update Submitted That Met QC Criteria

April 9, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe